The Unresolved Role of Interferon-λ in Asthma Bronchiale

Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany

Asthma bronchiale is a disease of the airways with increasing incidence, that often begins during infancy. So far, therapeutic options are mainly symptomatic and thus there is an increasing need for better treatment and/or prevention strategies. Human rhinoviruses (HRVs) are a major cause of asthma exacerbations and might cause acute wheezing associated with local production of pro-inflammatory mediators resulting in neutrophilic inflammatory response. Viral infections induce a characteristic activation of immune response, e.g., TLR3, 4, 7, 8, 9 in the endosome and their downstream targets, especially MyD88. Moreover, other cytoplasmic pattern recognition molecules (PRMs) like RIG1 and MDA5 play important roles in the activation of interferons (IFNs) of all types. Depending on the stimulation of the different PRMs, the levels of the IFNs induced might differ. Recent studies focused on Type I IFNs in samples from control and asthma patients. However, the administration of type I IFN-α was accompanied by side-effects, thus this possible therapy was abandoned. Type III IFN-λ acts more specifically, as fewer cells express the IFN-λ receptor chain 1. In addition, it has been shown that asthmatic mice treated with recombinant or adenoviral expressed IFN-λ2 (IL–28A) showed an amelioration of symptoms, indicating that treatment with IFN-λ might be beneficial for asthmatic patients.

 
Download Article (PDF)         Full text (html) 
 

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: The Allergy Matters Conference 2018 - TheAllergymatters https://t.co/90HR3WEHgV, see more https://t.co/CpGiFuOOYd
9hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: The Allergy Matters Conference 2018 - TheAllergymatters https://t.co/zOLj2SWQ8R, see more https://t.co/jgCeENQuZt
12hreplyretweetfavorite
Interasma RT @Aller_MD: Patients can keep a daily record of medication use and allergic rhinitis and asthma symptoms with a free #Allergy Diary app…
12hreplyretweetfavorite
Interasma RT @Aller_MD: iMedicalApps: This Week's Top Apps for iPhones and iPads https://t.co/9uKIumpKaM
12hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma